Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases

CG Schalkwijk, CDA Stehouwer - Physiological reviews, 2020 - journals.physiology.org
The formation and accumulation of methylglyoxal (MGO), a highly reactive dicarbonyl
compound, has been implicated in the pathogenesis of type 2 diabetes, vascular …

Advanced glycation end products and oxidative stress in type 2 diabetes mellitus

K Nowotny, T Jung, A Höhn, D Weber, T Grune - Biomolecules, 2015 - mdpi.com
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease
characterized by insulin resistance and β cell failure leading to elevated blood glucose …

[HTML][HTML] Role of advanced glycation end products in cellular signaling

C Ott, K Jacobs, E Haucke, AN Santos, T Grune… - Redox biology, 2014 - Elsevier
Improvements in health care and lifestyle have led to an elevated lifespan and increased
focus on age-associated diseases, such as neurodegeneration, cardiovascular disease …

The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases

DEM Maessen, CDA Stehouwer… - Clinical …, 2015 - portlandpress.com
The formation and accumulation of advanced glycation endproducts (AGEs) are related to
diabetes and other age-related diseases. Methylglyoxal (MGO), a highly reactive dicarbonyl …

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

JW Baynes, SR Thorpe - Diabetes, 1999 - Am Diabetes Assoc
Oxidative stress and oxidative damage to tissues are common end points of chronic
diseases, such as atherosclerosis, diabetes, and rheumatoid arthritis. The question …

Diabetes and advanced glycation endproducts

H Vlassara, MR Palace - Journal of internal medicine, 2002 - Wiley Online Library
Vlassara H, Palace MR (Department of Geriatrics, Division of Experimental Diabetes and
Ageing, Mount Sinai School of Medicine, and Department of Medicine, Division of …

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

A Bierhaus, MA Hofmann, R Ziegler… - Cardiovascular …, 1998 - academic.oup.com
Objective: This is the first part of a bipartite review that summarizes the rising knowledge on
the molecular mechanisms underlying the action of advanced glycation endproducts (AGEs) …

Increased accumulation of the glycoxidation product N (epsilon)-(carboxymethyl) lysine in human tissues in diabetes and aging.

ED Schleicher, E Wagner… - The Journal of clinical …, 1997 - Am Soc Clin Investig
N (epsilon)-(Carboxymethyl) lysine (CML), a major product of oxidative modification of
glycated proteins, has been suggested to represent a general marker of oxidative stress and …

N ε-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene …

T Kislinger, C Fu, B Huber, W Qu, A Taguchi… - Journal of Biological …, 1999 - ASBMB
Recent studies suggested that interruption of the interaction of advanced glycation end
products (AGEs), with the signal-transducing receptor receptor for AGE (RAGE), by …

Protein oxidation in aging and age‐related diseases

ER Stadtman - Annals of the new York Academy of Sciences, 2001 - Wiley Online Library
Although different theories have been proposed to explain the aging process, it is generally
agreed that there is a correlation between aging and the accumulation of oxidatively …